Glaukos Announces First Quarter 2026 Financial Results
Glaukos Corporation (GKOS)
Last glaukos corporation earnings: 2/27 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.glaukos.com/investors/investor-overview/default.aspx
Company Research
Source: Business Wire
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced financial results for the first quarter ended March 31, 2026. Key highlights include:Record net sales of $150.6 million in Q1 2026 increased 41% year-over-year on a reported basis and 39% year-over-year on a constant currency basis.Glaucoma record net sales of $129.3 million in Q1 2026 increased 47% year-over-year.U.S. Glaucoma record net sales of $93.5 million in Q1 2026 increased 58% year-over-year.Gross margin of approximately 78% and non-GAAP gross margin of approximately 84% in Q1 2026.Raised 2026 net sales guidance to $620 million to $635 million, compared to $600 million to $620 million previously.“Our record first quarter results reflect successful global execution across our key global commercial and development priorities, leavi
Show less
Read more
Impact Snapshot
Event Time:
GKOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GKOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GKOS alerts
High impacting Glaukos Corporation news events
Weekly update
A roundup of the hottest topics
GKOS
News
- Glaukos Announces the Release of its 2025 Sustainability ReportBusiness Wire
- Glaukos Receives Permanent J-code for Epioxa™ [Yahoo! Finance]Yahoo! Finance
- Glaukos Receives Permanent J-code for Epioxa™Business Wire
- Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29Business Wire
- Does Glaukos (GKOS) Using Epioxa at ASCRS Hint at a Broader Corneal-Health Strategy Shift? [Yahoo! Finance]Yahoo! Finance
GKOS
Earnings
- 4/29/26 - Beat
GKOS
Sec Filings
- 4/29/26 - Form SCHEDULE
- 4/29/26 - Form 8-K
- 4/29/26 - Form SCHEDULE
- GKOS's page on the SEC website